UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data

Drug and alcohol dependence, 2018-11, Vol.192, p.316-323

2018

Link zum Volltext

Verfügbarkeit prüfen

Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act

Journal of health care for the poor and underserved, 2014-02, Vol.25 (1 Suppl), p.36-45

2014

Link zum Volltext

Verfügbarkeit prüfen

Bupropion and Naltrexone in Methamphetamine Use Disorder

The New England journal of medicine, 2021-01, Vol.384 (2), p.140-153

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of BDNF and GDNF in drug reward and relapse: A review

Neuroscience and biobehavioral reviews, 2010-11, Vol.35 (2), p.157-171

2010

Link zum Volltext

Verfügbarkeit prüfen

Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes

Drug and alcohol dependence, 2018-05, Vol.186, p.86-93

2018

Link zum Volltext

Verfügbarkeit prüfen

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses

Addiction (Abingdon, England), 2023-07, Vol.118 (7), p.1307-1319

2023

Link zum Volltext

Verfügbarkeit prüfen

Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial

The American journal of psychiatry, 2014-06, Vol.171 (6), p.683-690

2014

Link zum Volltext

Verfügbarkeit prüfen

Commentary: Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders

Frontiers in psychiatry, 2017-01, Vol.8, p.2-2

Ghitza, Udi E

2017

Link zum Volltext

Verfügbarkeit prüfen

Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications

Frontiers in psychiatry, 2016-05, Vol.7, p.80-80

Ghitza, Udi E

2016

Link zum Volltext

Verfügbarkeit prüfen

Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network

Addiction (Abingdon, England), 2021-07, Vol.116 (7), p.1805-1816

2021

Link zum Volltext

Verfügbarkeit prüfen

Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment

Frontiers in psychiatry, 2015-03, Vol.6, p.37-37

Ghitza, Udi E

2015

Link zum Volltext

Verfügbarkeit prüfen

A randomized placebo-controlled trial of N -acetylcysteine for cannabis use disorder in adults

Drug and alcohol dependence, 2017-08, Vol.177, p.249-257

2017

Link zum Volltext

Verfügbarkeit prüfen

Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment

American Journal of Psychiatry, 2015-08, Vol.172 (8), p.760-767

2015

Link zum Volltext

Verfügbarkeit prüfen

Stress Impairs Reconsolidation of Drug Memory via Glucocorticoid Receptors in the Basolateral Amygdala

The Journal of neuroscience, 2008-05, Vol.28 (21), p.5602-5610

2008

Link zum Volltext

Verfügbarkeit prüfen

Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration

Drug and alcohol dependence, 2023-07, Vol.248, p.109902-109902, Article 109902

2023

Link zum Volltext

Verfügbarkeit prüfen

Neurobiology of relapse to heroin and cocaine seeking: An update and clinical implications

European journal of pharmacology, 2005-12, Vol.526 (1), p.36-50

2005

Link zum Volltext

Verfügbarkeit prüfen

Potential effect of antidepressants on remission from cocaine use disorder – A nationwide matched retrospective cohort study

Drug and alcohol dependence, 2023-10, Vol.251, p.110958-110958, Article 110958

2023

Link zum Volltext

Verfügbarkeit prüfen

Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study

The journal of pain, 2022-08, Vol.23 (8), p.1448-1459

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test

Drug and alcohol dependence, 2021-11, Vol.228, p.109067-109067, Article 109067

2021

Link zum Volltext

Verfügbarkeit prüfen

A Commentary on "A New Initiative on Precision Medicine"

Frontiers in psychiatry, 2015, Vol.6, p.88-88

Ghitza, Udi E

2015

Link zum Volltext

Verfügbarkeit prüfen

ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework

Frontiers in psychiatry, 2014-12, Vol.5, p.180-180

Ghitza, Udi E

2014

Link zum Volltext

Verfügbarkeit prüfen

Commentary: A Gene-Based Association Method for Mapping Traits Using Reference Transcriptome Data

Frontiers in psychiatry, 2016-04, Vol.7, p.73-73

Ghitza, Udi E

2016

Link zum Volltext

Verfügbarkeit prüfen

Commentary: Rewriting the Valuation and Salience of Alcohol-Related Stimuli via Memory Reconsolidation

Frontiers in psychiatry, 2016-03, Vol.7, p.41-41

Ghitza, Udi E

2016

Link zum Volltext

Verfügbarkeit prüfen

Clonidine blocks stress-induced craving in cocaine users

Psychopharmacology, 2011-11, Vol.218 (1), p.83-88

2011

Link zum Volltext

Verfügbarkeit prüfen

Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study

Drug and alcohol dependence, 2018-11, Vol.192, p.59-66

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data

Challenges and opportunities for integrating preventive substance-use-care services in primary care through the Affordable Care Act

Bupropion and Naltrexone in Methamphetamine Use Disorder

Role of BDNF and GDNF in drug reward and relapse: A review

Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses

Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial

Commentary: Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders

Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications

Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network

Needed Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment

A randomized placebo-controlled trial of N -acetylcysteine for cannabis use disorder in adults

Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment

Stress Impairs Reconsolidation of Drug Memory via Glucocorticoid Receptors in the Basolateral Amygdala

Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration

Neurobiology of relapse to heroin and cocaine seeking: An update and clinical implications

Potential effect of antidepressants on remission from cocaine use disorder – A nationwide matched retrospective cohort study

Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study

Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test

A Commentary on "A New Initiative on Precision Medicine"

ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine Framework

Commentary: A Gene-Based Association Method for Mapping Traits Using Reference Transcriptome Data

Commentary: Rewriting the Valuation and Salience of Alcohol-Related Stimuli via Memory Reconsolidation

Clonidine blocks stress-induced craving in cocaine users

Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study

Suchergebnisse filtern